instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypokalaemia'. | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | CLENBUTEROL, DROMOSTANOLONE, FLUOXYMESTERONE, LETROZOLE, LEVOTHYROXINE SODIUM, MESTEROLONE, OXANDROLONE, STANOZOLOL, TRENBOLONE | DrugsGivenReaction | CC BY-NC-ND | 34612209 | 20,333,428 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypophosphataemia'. | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | CLENBUTEROL, DROMOSTANOLONE, FLUOXYMESTERONE, LETROZOLE, LEVOTHYROXINE, MESTEROLONE, OXANDROLONE, STANOZOLOL, TRENBOLONE | DrugsGivenReaction | CC BY-NC-ND | 34612209 | 20,709,391 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metabolic alkalosis'. | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | CLENBUTEROL, DROMOSTANOLONE, FLUOXYMESTERONE, LETROZOLE, LEVOTHYROXINE, MESTEROLONE, OXANDROLONE, STANOZOLOL, TRENBOLONE | DrugsGivenReaction | CC BY-NC-ND | 34612209 | 20,709,391 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocardial fibrosis'. | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | CLENBUTEROL, DROMOSTANOLONE, FLUOXYMESTERONE, LETROZOLE, LEVOTHYROXINE, MESTEROLONE, OXANDROLONE, STANOZOLOL, TRENBOLONE | DrugsGivenReaction | CC BY-NC-ND | 34612209 | 20,709,391 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocardial injury'. | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | CLENBUTEROL, DROMOSTANOLONE, FLUOXYMESTERONE, LETROZOLE, LEVOTHYROXINE, MESTEROLONE, OXANDROLONE, STANOZOLOL, TRENBOLONE | DrugsGivenReaction | CC BY-NC-ND | 34612209 | 20,723,101 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oestradiol increased'. | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | CLENBUTEROL, DROMOSTANOLONE, FLUOXYMESTERONE, LETROZOLE, LEVOTHYROXINE, MESTEROLONE, OXANDROLONE, STANOZOLOL, TRENBOLONE | DrugsGivenReaction | CC BY-NC-ND | 34612209 | 20,709,391 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | CLENBUTEROL, DROMOSTANOLONE, FLUOXYMESTERONE, LETROZOLE, LEVOTHYROXINE, MESTEROLONE, OXANDROLONE, STANOZOLOL, TRENBOLONE ACETATE | DrugsGivenReaction | CC BY-NC-ND | 34612209 | 20,712,159 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Prescription drug used without a prescription'. | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | CLENBUTEROL, DROMOSTANOLONE, FLUOXYMESTERONE, LETROZOLE, LEVOTHYROXINE, MESTEROLONE, OXANDROLONE, STANOZOLOL, TRENBOLONE | DrugsGivenReaction | CC BY-NC-ND | 34612209 | 20,723,101 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rhabdomyolysis'. | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | CLENBUTEROL, DROMOSTANOLONE, FLUOXYMESTERONE, LETROZOLE, LEVOTHYROXINE, MESTEROLONE, OXANDROLONE, STANOZOLOL, TRENBOLONE | DrugsGivenReaction | CC BY-NC-ND | 34612209 | 20,709,391 | 2021-10-01 |
What was the administration route of drug 'LEVOTHYROXINE'? | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34612209 | 20,712,159 | 2021-10-01 |
What was the outcome of reaction 'Blood testosterone increased'? | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34612209 | 20,709,391 | 2021-10-01 |
What was the outcome of reaction 'Electrocardiogram QT prolonged'? | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | Recovered | ReactionOutcome | CC BY-NC-ND | 34612209 | 20,723,101 | 2021-10-01 |
What was the outcome of reaction 'Hyperglycaemia'? | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | Recovered | ReactionOutcome | CC BY-NC-ND | 34612209 | 20,723,101 | 2021-10-01 |
What was the outcome of reaction 'Hyperthyroidism'? | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | Recovered | ReactionOutcome | CC BY-NC-ND | 34612209 | 20,333,428 | 2021-10-01 |
What was the outcome of reaction 'Hypertransaminasaemia'? | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | Recovered | ReactionOutcome | CC BY-NC-ND | 34612209 | 20,723,101 | 2021-10-01 |
What was the outcome of reaction 'Hypokalaemia'? | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | Recovered | ReactionOutcome | CC BY-NC-ND | 34612209 | 20,333,428 | 2021-10-01 |
What was the outcome of reaction 'Hypophosphataemia'? | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | Recovered | ReactionOutcome | CC BY-NC-ND | 34612209 | 20,709,391 | 2021-10-01 |
What was the outcome of reaction 'Intentional product misuse'? | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | Recovered | ReactionOutcome | CC BY-NC-ND | 34612209 | 20,333,428 | 2021-10-01 |
What was the outcome of reaction 'Metabolic alkalosis'? | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | Recovered | ReactionOutcome | CC BY-NC-ND | 34612209 | 20,709,391 | 2021-10-01 |
What was the outcome of reaction 'Myocardial fibrosis'? | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34612209 | 20,709,391 | 2021-10-01 |
What was the outcome of reaction 'Myocardial injury'? | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | Recovered | ReactionOutcome | CC BY-NC-ND | 34612209 | 20,723,101 | 2021-10-01 |
What was the outcome of reaction 'Oestradiol increased'? | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34612209 | 20,709,391 | 2021-10-01 |
What was the outcome of reaction 'Rhabdomyolysis'? | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | Recovered | ReactionOutcome | CC BY-NC-ND | 34612209 | 20,709,391 | 2021-10-01 |
What was the outcome of reaction 'Thyrotoxic periodic paralysis'? | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | Recovered | ReactionOutcome | CC BY-NC-ND | 34612209 | 20,333,428 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fluid retention'. | Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome.
Glut1 deficiency syndrome is caused by SLC2A1 mutations on chromosome 1p34.2 that impairs glucose transport across the blood-brain barrier resulting in hypoglycorrhachia and decreased fuel for brain metabolism. Neuroglycop... | DIAZOXIDE | DrugsGivenReaction | CC BY | 34612610 | 20,357,754 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypokalaemia'. | Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome.
Glut1 deficiency syndrome is caused by SLC2A1 mutations on chromosome 1p34.2 that impairs glucose transport across the blood-brain barrier resulting in hypoglycorrhachia and decreased fuel for brain metabolism. Neuroglycop... | .ALPHA.-LIPOIC ACID, ACETAZOLAMIDE, AMILORIDE, CARBAMAZEPINE, DIAZOXIDE, HYDROCHLOROTHIAZIDE, LACOSAMIDE, LEVETIRACETAM, TRIHEPTANOIN, VALPROIC ACID, ZONISAMIDE | DrugsGivenReaction | CC BY | 34612610 | 20,365,073 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal failure'. | Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome.
Glut1 deficiency syndrome is caused by SLC2A1 mutations on chromosome 1p34.2 that impairs glucose transport across the blood-brain barrier resulting in hypoglycorrhachia and decreased fuel for brain metabolism. Neuroglycop... | .ALPHA.-LIPOIC ACID, ACETAZOLAMIDE, AMILORIDE, CARBAMAZEPINE, DIAZOXIDE, HYDROCHLOROTHIAZIDE, LACOSAMIDE, LEVETIRACETAM, TRIHEPTANOIN, VALPROIC ACID, ZONISAMIDE | DrugsGivenReaction | CC BY | 34612610 | 20,365,073 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight increased'. | Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome.
Glut1 deficiency syndrome is caused by SLC2A1 mutations on chromosome 1p34.2 that impairs glucose transport across the blood-brain barrier resulting in hypoglycorrhachia and decreased fuel for brain metabolism. Neuroglycop... | DIAZOXIDE | DrugsGivenReaction | CC BY | 34612610 | 20,357,754 | 2021-11 |
What was the dosage of drug 'DIAZOXIDE'? | Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome.
Glut1 deficiency syndrome is caused by SLC2A1 mutations on chromosome 1p34.2 that impairs glucose transport across the blood-brain barrier resulting in hypoglycorrhachia and decreased fuel for brain metabolism. Neuroglycop... | 7.6 MILLIGRAM/KILOGRAM, ONCE A DAY | DrugDosageText | CC BY | 34612610 | 20,365,073 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myalgia'. | An Atypical Phenotype of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated with Ocular Palsy, IgM-anti Ganglioside Antibody, and Fever-induced Recurrence.
We herein report a case of recurrent multifocal, distal-dominant-sensorimotor neuropathy with ophthalmoplegia, IgM anti-GM1 antibody, and pyrexia-... | DEXAMETHASONE | DrugsGivenReaction | CC BY-NC-ND | 34615817 | 20,838,190 | 2021-10-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | An Atypical Phenotype of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated with Ocular Palsy, IgM-anti Ganglioside Antibody, and Fever-induced Recurrence.
We herein report a case of recurrent multifocal, distal-dominant-sensorimotor neuropathy with ophthalmoplegia, IgM anti-GM1 antibody, and pyrexia-... | DEXAMETHASONE | DrugsGivenReaction | CC BY-NC-ND | 34615817 | 20,838,190 | 2021-10-05 |
What was the administration route of drug 'DEXAMETHASONE'? | An Atypical Phenotype of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated with Ocular Palsy, IgM-anti Ganglioside Antibody, and Fever-induced Recurrence.
We herein report a case of recurrent multifocal, distal-dominant-sensorimotor neuropathy with ophthalmoplegia, IgM anti-GM1 antibody, and pyrexia-... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34615817 | 20,838,190 | 2021-10-05 |
What was the outcome of reaction 'Myalgia'? | An Atypical Phenotype of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated with Ocular Palsy, IgM-anti Ganglioside Antibody, and Fever-induced Recurrence.
We herein report a case of recurrent multifocal, distal-dominant-sensorimotor neuropathy with ophthalmoplegia, IgM anti-GM1 antibody, and pyrexia-... | Recovering | ReactionOutcome | CC BY-NC-ND | 34615817 | 20,838,190 | 2021-10-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intestinal haemorrhage'. | Acute Coronary Syndrome Developed in a 17-year-old boy with Sitosterolemia Comorbid with Takayasu Arteritis: A Rare Case Report and Review of the Literature.
A 17-year-old boy with acute coronary syndrome was admitted to our hospital. He had xanthomas over his elbow and Achilles tendon and a high level of low-density l... | CLOPIDOGREL BISULFATE, EVOLOCUMAB, EZETIMIBE, PREDNISOLONE, PROBUCOL, ROSUVASTATIN, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34615826 | 20,901,499 | 2021-10-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Platelet count decreased'. | Acute Coronary Syndrome Developed in a 17-year-old boy with Sitosterolemia Comorbid with Takayasu Arteritis: A Rare Case Report and Review of the Literature.
A 17-year-old boy with acute coronary syndrome was admitted to our hospital. He had xanthomas over his elbow and Achilles tendon and a high level of low-density l... | CLOPIDOGREL BISULFATE, EVOLOCUMAB, EZETIMIBE, PREDNISOLONE, PROBUCOL, ROSUVASTATIN, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34615826 | 20,901,499 | 2021-10-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Platelet morphology abnormal'. | Acute Coronary Syndrome Developed in a 17-year-old boy with Sitosterolemia Comorbid with Takayasu Arteritis: A Rare Case Report and Review of the Literature.
A 17-year-old boy with acute coronary syndrome was admitted to our hospital. He had xanthomas over his elbow and Achilles tendon and a high level of low-density l... | CLOPIDOGREL BISULFATE, EVOLOCUMAB, EZETIMIBE, PREDNISOLONE, PROBUCOL, ROSUVASTATIN, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34615826 | 20,901,499 | 2021-10-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Takayasu^s arteritis'. | Acute Coronary Syndrome Developed in a 17-year-old boy with Sitosterolemia Comorbid with Takayasu Arteritis: A Rare Case Report and Review of the Literature.
A 17-year-old boy with acute coronary syndrome was admitted to our hospital. He had xanthomas over his elbow and Achilles tendon and a high level of low-density l... | CLOPIDOGREL BISULFATE, EVOLOCUMAB, EZETIMIBE, PREDNISOLONE, PROBUCOL, ROSUVASTATIN, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34615826 | 20,901,499 | 2021-10-05 |
What was the administration route of drug 'EVOLOCUMAB'? | Acute Coronary Syndrome Developed in a 17-year-old boy with Sitosterolemia Comorbid with Takayasu Arteritis: A Rare Case Report and Review of the Literature.
A 17-year-old boy with acute coronary syndrome was admitted to our hospital. He had xanthomas over his elbow and Achilles tendon and a high level of low-density l... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 34615826 | 20,901,499 | 2021-10-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cross sensitivity reaction'. | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | APIXABAN, CEFAZOLIN, ENOXAPARIN, INSULIN NOS, METRONIDAZOLE, RIVAROXABAN | DrugsGivenReaction | CC BY-NC | 34616187 | 20,745,579 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug hypersensitivity'. | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | APIXABAN, CEFAZOLIN, ENOXAPARIN, INSULIN NOS, METRONIDAZOLE, RIVAROXABAN | DrugsGivenReaction | CC BY-NC | 34616187 | 19,984,876 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypersensitivity'. | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | APIXABAN, CEFAZOLIN, ENOXAPARIN, INSULIN NOS, METRONIDAZOLE, RIVAROXABAN | DrugsGivenReaction | CC BY-NC | 34616187 | 20,745,579 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Purpura'. | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | APIXABAN, CEFAZOLIN, ENOXAPARIN, INSULIN NOS, METRONIDAZOLE, RIVAROXABAN | DrugsGivenReaction | CC BY-NC | 34616187 | 20,745,579 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash maculo-papular'. | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | APIXABAN, RIVAROXABAN | DrugsGivenReaction | CC BY-NC | 34616187 | 19,992,393 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash pruritic'. | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | APIXABAN, CEFAZOLIN, ENOXAPARIN, INSULIN NOS, METRONIDAZOLE, RIVAROXABAN | DrugsGivenReaction | CC BY-NC | 34616187 | 19,984,876 | 2021 |
What was the administration route of drug 'APIXABAN'? | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | Oral | DrugAdministrationRoute | CC BY-NC | 34616187 | 19,992,393 | 2021 |
What was the administration route of drug 'CEFAZOLIN'? | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34616187 | 19,984,876 | 2021 |
What was the administration route of drug 'ENOXAPARIN'? | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 34616187 | 19,984,876 | 2021 |
What was the administration route of drug 'METRONIDAZOLE'? | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | Oral | DrugAdministrationRoute | CC BY-NC | 34616187 | 19,984,876 | 2021 |
What was the administration route of drug 'RIVAROXABAN'? | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | Oral | DrugAdministrationRoute | CC BY-NC | 34616187 | 19,984,876 | 2021 |
What was the outcome of reaction 'Cross sensitivity reaction'? | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | Recovered | ReactionOutcome | CC BY-NC | 34616187 | 20,745,579 | 2021 |
What was the outcome of reaction 'Drug hypersensitivity'? | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | Recovered | ReactionOutcome | CC BY-NC | 34616187 | 19,984,876 | 2021 |
What was the outcome of reaction 'Hypersensitivity'? | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | Recovered | ReactionOutcome | CC BY-NC | 34616187 | 20,745,579 | 2021 |
What was the outcome of reaction 'Purpura'? | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | Recovered | ReactionOutcome | CC BY-NC | 34616187 | 20,745,579 | 2021 |
What was the outcome of reaction 'Rash maculo-papular'? | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | Recovered | ReactionOutcome | CC BY-NC | 34616187 | 19,992,393 | 2021 |
What was the outcome of reaction 'Rash pruritic'? | Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban.
Direct oral anticoagulants (DOACs) have gained increasing popularity in clinical practice in the past decade. While DOACs have fewer associated adverse events as compared to warfarin, DOAC-i... | Recovered | ReactionOutcome | CC BY-NC | 34616187 | 19,984,876 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Superimposed Infectious Colitis in Crohn's Disease.
The differential diagnosis for an acute Crohn's flare should include enteric infection, a challenging yet critical distinction to make when determining appropriate therapy. Since both present similarly, identification of an enteric infection should be performed with c... | METRONIDAZOLE, PREDNISONE, VEDOLIZUMAB | DrugsGivenReaction | CC BY-NC | 34616242 | 20,204,628 | 2021 |
What was the administration route of drug 'OCTREOTIDE'? | Upper GI Bleeding Secondary to Radiation Gastritis in a Patient with Preexisting Portal Hypertensive Gastropathy.
We commonly see patients presenting with either portal hypertensive gastropathy (PHG) or radiation gastritis. Radiation-induced hemorrhagic gastritis is an unusual lethal complication postradiation. Patient... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 34616249 | 20,215,994 | 2021 |
What was the dosage of drug 'OCTREOTIDE'? | Upper GI Bleeding Secondary to Radiation Gastritis in a Patient with Preexisting Portal Hypertensive Gastropathy.
We commonly see patients presenting with either portal hypertensive gastropathy (PHG) or radiation gastritis. Radiation-induced hemorrhagic gastritis is an unusual lethal complication postradiation. Patient... | UNK, BID (THERAPY COMPLETED) | DrugDosageText | CC BY-NC | 34616249 | 20,215,994 | 2021 |
What was the dosage of drug 'PANTOPRAZOLE'? | Upper GI Bleeding Secondary to Radiation Gastritis in a Patient with Preexisting Portal Hypertensive Gastropathy.
We commonly see patients presenting with either portal hypertensive gastropathy (PHG) or radiation gastritis. Radiation-induced hemorrhagic gastritis is an unusual lethal complication postradiation. Patient... | UNK, BID (THERAPY COMPLETED) | DrugDosageText | CC BY-NC | 34616249 | 20,215,994 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Proton Pump Inhibitor-Associated Large Hyperplastic Polyp in Non-Helicobacter pylori-Infected Stomach.
A proton pump inhibitor (PPI)-associated hyperplastic polyp (HP) in the non-Helicobacter pylori-infected stomach is rare, and its endoscopic features remain poorly described. A 42-year-old man with tarry stool was ref... | BERAPROST SODIUM, ICOSAPENT ETHYL, PREDNISOLONE, RABEPRAZOLE | DrugsGivenReaction | CC BY-NC | 34616253 | 20,011,295 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastric polyps'. | Proton Pump Inhibitor-Associated Large Hyperplastic Polyp in Non-Helicobacter pylori-Infected Stomach.
A proton pump inhibitor (PPI)-associated hyperplastic polyp (HP) in the non-Helicobacter pylori-infected stomach is rare, and its endoscopic features remain poorly described. A 42-year-old man with tarry stool was ref... | BERAPROST SODIUM, ICOSAPENT ETHYL, PREDNISOLONE, RABEPRAZOLE | DrugsGivenReaction | CC BY-NC | 34616253 | 20,084,724 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal polyp haemorrhage'. | Proton Pump Inhibitor-Associated Large Hyperplastic Polyp in Non-Helicobacter pylori-Infected Stomach.
A proton pump inhibitor (PPI)-associated hyperplastic polyp (HP) in the non-Helicobacter pylori-infected stomach is rare, and its endoscopic features remain poorly described. A 42-year-old man with tarry stool was ref... | BERAPROST SODIUM, ICOSAPENT ETHYL, PREDNISOLONE, RABEPRAZOLE | DrugsGivenReaction | CC BY-NC | 34616253 | 20,084,724 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypergastrinaemia'. | Proton Pump Inhibitor-Associated Large Hyperplastic Polyp in Non-Helicobacter pylori-Infected Stomach.
A proton pump inhibitor (PPI)-associated hyperplastic polyp (HP) in the non-Helicobacter pylori-infected stomach is rare, and its endoscopic features remain poorly described. A 42-year-old man with tarry stool was ref... | BERAPROST SODIUM, ICOSAPENT ETHYL, PREDNISOLONE, RABEPRAZOLE | DrugsGivenReaction | CC BY-NC | 34616253 | 20,011,295 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Polyp'. | Proton Pump Inhibitor-Associated Large Hyperplastic Polyp in Non-Helicobacter pylori-Infected Stomach.
A proton pump inhibitor (PPI)-associated hyperplastic polyp (HP) in the non-Helicobacter pylori-infected stomach is rare, and its endoscopic features remain poorly described. A 42-year-old man with tarry stool was ref... | BERAPROST SODIUM, ICOSAPENT ETHYL, PREDNISOLONE, RABEPRAZOLE | DrugsGivenReaction | CC BY-NC | 34616253 | 20,011,295 | 2021 |
What was the administration route of drug 'RABEPRAZOLE'? | Proton Pump Inhibitor-Associated Large Hyperplastic Polyp in Non-Helicobacter pylori-Infected Stomach.
A proton pump inhibitor (PPI)-associated hyperplastic polyp (HP) in the non-Helicobacter pylori-infected stomach is rare, and its endoscopic features remain poorly described. A 42-year-old man with tarry stool was ref... | Oral | DrugAdministrationRoute | CC BY-NC | 34616253 | 20,011,295 | 2021 |
What was the dosage of drug 'BERAPROST SODIUM'? | Proton Pump Inhibitor-Associated Large Hyperplastic Polyp in Non-Helicobacter pylori-Infected Stomach.
A proton pump inhibitor (PPI)-associated hyperplastic polyp (HP) in the non-Helicobacter pylori-infected stomach is rare, and its endoscopic features remain poorly described. A 42-year-old man with tarry stool was ref... | DOSE AND FREQUENCY UNKNOWN | DrugDosageText | CC BY-NC | 34616253 | 20,011,295 | 2021 |
What was the dosage of drug 'ICOSAPENT ETHYL'? | Proton Pump Inhibitor-Associated Large Hyperplastic Polyp in Non-Helicobacter pylori-Infected Stomach.
A proton pump inhibitor (PPI)-associated hyperplastic polyp (HP) in the non-Helicobacter pylori-infected stomach is rare, and its endoscopic features remain poorly described. A 42-year-old man with tarry stool was ref... | DOSE AND FREQUENCY UNKNOWN | DrugDosageText | CC BY-NC | 34616253 | 20,011,295 | 2021 |
What was the dosage of drug 'PREDNISOLONE'? | Proton Pump Inhibitor-Associated Large Hyperplastic Polyp in Non-Helicobacter pylori-Infected Stomach.
A proton pump inhibitor (PPI)-associated hyperplastic polyp (HP) in the non-Helicobacter pylori-infected stomach is rare, and its endoscopic features remain poorly described. A 42-year-old man with tarry stool was ref... | DOSE AND FREQUENCY UNKNOWN | DrugDosageText | CC BY-NC | 34616253 | 20,011,295 | 2021 |
What was the outcome of reaction 'Anaemia'? | Proton Pump Inhibitor-Associated Large Hyperplastic Polyp in Non-Helicobacter pylori-Infected Stomach.
A proton pump inhibitor (PPI)-associated hyperplastic polyp (HP) in the non-Helicobacter pylori-infected stomach is rare, and its endoscopic features remain poorly described. A 42-year-old man with tarry stool was ref... | Recovered | ReactionOutcome | CC BY-NC | 34616253 | 20,011,295 | 2021 |
What was the outcome of reaction 'Gastric polyps'? | Proton Pump Inhibitor-Associated Large Hyperplastic Polyp in Non-Helicobacter pylori-Infected Stomach.
A proton pump inhibitor (PPI)-associated hyperplastic polyp (HP) in the non-Helicobacter pylori-infected stomach is rare, and its endoscopic features remain poorly described. A 42-year-old man with tarry stool was ref... | Recovered | ReactionOutcome | CC BY-NC | 34616253 | 20,084,724 | 2021 |
What was the outcome of reaction 'Gastrointestinal polyp haemorrhage'? | Proton Pump Inhibitor-Associated Large Hyperplastic Polyp in Non-Helicobacter pylori-Infected Stomach.
A proton pump inhibitor (PPI)-associated hyperplastic polyp (HP) in the non-Helicobacter pylori-infected stomach is rare, and its endoscopic features remain poorly described. A 42-year-old man with tarry stool was ref... | Recovered | ReactionOutcome | CC BY-NC | 34616253 | 20,084,724 | 2021 |
What was the outcome of reaction 'Hypergastrinaemia'? | Proton Pump Inhibitor-Associated Large Hyperplastic Polyp in Non-Helicobacter pylori-Infected Stomach.
A proton pump inhibitor (PPI)-associated hyperplastic polyp (HP) in the non-Helicobacter pylori-infected stomach is rare, and its endoscopic features remain poorly described. A 42-year-old man with tarry stool was ref... | Recovered | ReactionOutcome | CC BY-NC | 34616253 | 20,011,295 | 2021 |
What was the outcome of reaction 'Polyp'? | Proton Pump Inhibitor-Associated Large Hyperplastic Polyp in Non-Helicobacter pylori-Infected Stomach.
A proton pump inhibitor (PPI)-associated hyperplastic polyp (HP) in the non-Helicobacter pylori-infected stomach is rare, and its endoscopic features remain poorly described. A 42-year-old man with tarry stool was ref... | Recovered | ReactionOutcome | CC BY-NC | 34616253 | 20,011,295 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immunosuppression'. | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | ALBUTEROL\IPRATROPIUM, ASPIRIN, BUDESONIDE, HYDROCHLOROTHIAZIDE, MAGNESIUM, METFORMIN HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, NITROGLYCERIN, OXYGEN | DrugsGivenReaction | CC BY-NC | 34616265 | 19,746,512 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oesophageal ulcer haemorrhage'. | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | ALBUTEROL\IPRATROPIUM, ASPIRIN, BUDESONIDE, HYDROCHLOROTHIAZIDE, MAGNESIUM, METFORMIN HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, NITROGLYCERIN, OXYGEN | DrugsGivenReaction | CC BY-NC | 34616265 | 19,746,512 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | ALBUTEROL\IPRATROPIUM, ASPIRIN, BUDESONIDE, HYDROCHLOROTHIAZIDE, MAGNESIUM, METFORMIN HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, NITROGLYCERIN, OXYGEN | DrugsGivenReaction | CC BY-NC | 34616265 | 19,746,512 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34616265 | 20,543,378 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34616265 | 20,504,698 | 2021 |
What was the administration route of drug 'NITROGLYCERIN'? | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34616265 | 20,543,378 | 2021 |
What was the dosage of drug 'ASPIRIN'? | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | UNKNOWN | DrugDosageText | CC BY-NC | 34616265 | 19,785,533 | 2021 |
What was the dosage of drug 'HYDROCHLOROTHIAZIDE'? | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | UNKNOWN | DrugDosageText | CC BY-NC | 34616265 | 19,785,533 | 2021 |
What was the dosage of drug 'MAGNESIUM'? | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | UNKNOWN | DrugDosageText | CC BY-NC | 34616265 | 19,785,533 | 2021 |
What was the dosage of drug 'METFORMIN HYDROCHLORIDE'? | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | UNKNOWN | DrugDosageText | CC BY-NC | 34616265 | 19,785,533 | 2021 |
What was the dosage of drug 'NITROGLYCERIN'? | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | UNKNOWN | DrugDosageText | CC BY-NC | 34616265 | 19,785,533 | 2021 |
What was the outcome of reaction 'Gastrointestinal haemorrhage'? | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | Recovered | ReactionOutcome | CC BY-NC | 34616265 | 20,543,378 | 2021 |
What was the outcome of reaction 'Haematemesis'? | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | Recovered | ReactionOutcome | CC BY-NC | 34616265 | 20,543,378 | 2021 |
What was the outcome of reaction 'Herpes oesophagitis'? | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | Recovered | ReactionOutcome | CC BY-NC | 34616265 | 20,504,698 | 2021 |
What was the outcome of reaction 'Herpes simplex oesophagitis'? | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | Recovered | ReactionOutcome | CC BY-NC | 34616265 | 20,543,378 | 2021 |
What was the outcome of reaction 'Oesophageal ulcer haemorrhage'? | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | Recovered | ReactionOutcome | CC BY-NC | 34616265 | 19,746,512 | 2021 |
What was the outcome of reaction 'Oesophageal ulcer'? | Herpes Simplex Virus Esophagitis in the Setting of Acute Use of Corticosteroids for COPD Exacerbation in an Immunocompetent Middle-Aged Woman.
Herpes simplex (HSV) esophagitis is usually identified in patients with significant immunosuppressive conditions such as AIDS. Short course of immunosuppressive therapy is an un... | Recovered | ReactionOutcome | CC BY-NC | 34616265 | 20,543,378 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vulvovaginal candidiasis'. | Multidrug Resistance and Flaring up of Manifestation in Fistulizing Crohn's Disease after Surgery on a Perianal Lesion.
Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract with relapsing and remitting episodes. Abscesses and fistulas are the most common presentations of anorectal Crohn's dis... | BUDESONIDE, HYDROCORTISONE, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 34616267 | 20,299,385 | 2021 |
What was the administration route of drug 'BUDESONIDE'? | Multidrug Resistance and Flaring up of Manifestation in Fistulizing Crohn's Disease after Surgery on a Perianal Lesion.
Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract with relapsing and remitting episodes. Abscesses and fistulas are the most common presentations of anorectal Crohn's dis... | Oral | DrugAdministrationRoute | CC BY-NC | 34616267 | 20,299,385 | 2021 |
What was the administration route of drug 'HYDROCORTISONE'? | Multidrug Resistance and Flaring up of Manifestation in Fistulizing Crohn's Disease after Surgery on a Perianal Lesion.
Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract with relapsing and remitting episodes. Abscesses and fistulas are the most common presentations of anorectal Crohn's dis... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34616267 | 20,299,385 | 2021 |
What was the administration route of drug 'USTEKINUMAB'? | Multidrug Resistance and Flaring up of Manifestation in Fistulizing Crohn's Disease after Surgery on a Perianal Lesion.
Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract with relapsing and remitting episodes. Abscesses and fistulas are the most common presentations of anorectal Crohn's dis... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 34616267 | 20,299,385 | 2021 |
What was the dosage of drug 'HYDROCORTISONE'? | Multidrug Resistance and Flaring up of Manifestation in Fistulizing Crohn's Disease after Surgery on a Perianal Lesion.
Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract with relapsing and remitting episodes. Abscesses and fistulas are the most common presentations of anorectal Crohn's dis... | 100 MG | DrugDosageText | CC BY-NC | 34616267 | 20,299,385 | 2021 |
What was the dosage of drug 'USTEKINUMAB'? | Multidrug Resistance and Flaring up of Manifestation in Fistulizing Crohn's Disease after Surgery on a Perianal Lesion.
Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract with relapsing and remitting episodes. Abscesses and fistulas are the most common presentations of anorectal Crohn's dis... | UNK, MONTHLY | DrugDosageText | CC BY-NC | 34616267 | 20,299,385 | 2021 |
What was the outcome of reaction 'Vulvovaginal candidiasis'? | Multidrug Resistance and Flaring up of Manifestation in Fistulizing Crohn's Disease after Surgery on a Perianal Lesion.
Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract with relapsing and remitting episodes. Abscesses and fistulas are the most common presentations of anorectal Crohn's dis... | Not recovered | ReactionOutcome | CC BY-NC | 34616267 | 20,299,385 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cholestasis'. | Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment.
The increased use of immune-checkpoint inhibitors to treat various types of cancer has increased the incidence of immune-related adverse events (irAEs). Hepatic irAEs are frequent and can lead to serious... | IPILIMUMAB, METHYLPREDNISOLONE, NIVOLUMAB, PAZOPANIB, PHYTONADIONE, PREDNISOLONE, URSODIOL | DrugsGivenReaction | CC BY-NC | 34616270 | 20,306,696 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cholestatic liver injury'. | Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment.
The increased use of immune-checkpoint inhibitors to treat various types of cancer has increased the incidence of immune-related adverse events (irAEs). Hepatic irAEs are frequent and can lead to serious... | IPILIMUMAB, METHYLPREDNISOLONE, NIVOLUMAB, PAZOPANIB, PHYTONADIONE, PREDNISOLONE, URSODIOL | DrugsGivenReaction | CC BY-NC | 34616270 | 20,306,696 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment.
The increased use of immune-checkpoint inhibitors to treat various types of cancer has increased the incidence of immune-related adverse events (irAEs). Hepatic irAEs are frequent and can lead to serious... | IPILIMUMAB, METHYLPREDNISOLONE, NIVOLUMAB, PAZOPANIB, PHYTONADIONE, PREDNISOLONE, URSODIOL | DrugsGivenReaction | CC BY-NC | 34616270 | 20,288,629 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.